IT1224513B - Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria - Google Patents

Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria

Info

Publication number
IT1224513B
IT1224513B IT8848208A IT4820888A IT1224513B IT 1224513 B IT1224513 B IT 1224513B IT 8848208 A IT8848208 A IT 8848208A IT 4820888 A IT4820888 A IT 4820888A IT 1224513 B IT1224513 B IT 1224513B
Authority
IT
Italy
Prior art keywords
derivative
monosialogangliosi
isopropylic
interests
nervous
Prior art date
Application number
IT8848208A
Other languages
English (en)
Other versions
IT8848208A0 (it
Inventor
Della Valle Francesco
Romeo Aurelio
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Publication of IT8848208A0 publication Critical patent/IT8848208A0/it
Priority to IT8848208A priority Critical patent/IT1224513B/it
Priority to ZA895367A priority patent/ZA895367B/xx
Priority to PH38954A priority patent/PH26117A/en
Priority to AU38190/89A priority patent/AU624164B2/en
Priority to DE68911049T priority patent/DE68911049T2/de
Priority to DK354589A priority patent/DK354589A/da
Priority to ES89113160T priority patent/ES2061821T3/es
Priority to EP89113160A priority patent/EP0351784B1/en
Priority to AT89113160T priority patent/ATE97812T1/de
Priority to JP1187237A priority patent/JPH0278622A/ja
Application granted granted Critical
Publication of IT1224513B publication Critical patent/IT1224513B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IT8848208A 1988-07-19 1988-07-19 Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria IT1224513B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT8848208A IT1224513B (it) 1988-07-19 1988-07-19 Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria
ZA895367A ZA895367B (en) 1988-07-19 1989-07-14 Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component
PH38954A PH26117A (en) 1988-07-19 1989-07-17 Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component
DE68911049T DE68911049T2 (de) 1988-07-19 1989-07-18 Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen.
AU38190/89A AU624164B2 (en) 1988-07-19 1989-07-18 Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component
DK354589A DK354589A (da) 1988-07-19 1989-07-18 Anvendelse af gangliosidderivater
ES89113160T ES2061821T3 (es) 1988-07-19 1989-07-18 Utilizacion terapeutica del derivado ester isopropilo de monosialgangliosido en patologias nerviosas con componente inflamatoria.
EP89113160A EP0351784B1 (en) 1988-07-19 1989-07-18 Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component
AT89113160T ATE97812T1 (de) 1988-07-19 1989-07-18 Therapeutische verwendung des isopropylesterderivates von monosialogangliosiden bei erkrankungen des nervensystems, begleitet von entzuendungen.
JP1187237A JPH0278622A (ja) 1988-07-19 1989-07-19 モノシアロガングリオシドのイソプロピルエステル誘導体の治療用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848208A IT1224513B (it) 1988-07-19 1988-07-19 Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria

Publications (2)

Publication Number Publication Date
IT8848208A0 IT8848208A0 (it) 1988-07-19
IT1224513B true IT1224513B (it) 1990-10-04

Family

ID=11265246

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8848208A IT1224513B (it) 1988-07-19 1988-07-19 Uso terapeutico del derivato estere isopropilico del monosialogangliosi de in patologie ad interessamento nervoso con componente infiammatoria

Country Status (10)

Country Link
EP (1) EP0351784B1 (it)
JP (1) JPH0278622A (it)
AT (1) ATE97812T1 (it)
AU (1) AU624164B2 (it)
DE (1) DE68911049T2 (it)
DK (1) DK354589A (it)
ES (1) ES2061821T3 (it)
IT (1) IT1224513B (it)
PH (1) PH26117A (it)
ZA (1) ZA895367B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
US6998392B2 (en) 2003-04-02 2006-02-14 Mti Meta Tech Inc. Formulation to treat or prevent parasitic infection
US7851451B2 (en) 2004-03-12 2010-12-14 Mti Meta Tech Inc. Formulations for mediating inflammatory bowel disorders
US8536140B2 (en) 2004-03-12 2013-09-17 Mti Meta Tech Inc. Methods for treating inflammatory bowel disease
CN104490837A (zh) * 2014-12-30 2015-04-08 哈尔滨医科大学科技开发总公司 单唾液酸四己糖神经节苷脂钠的口服制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi

Also Published As

Publication number Publication date
DE68911049T2 (de) 1994-06-01
AU624164B2 (en) 1992-06-04
ZA895367B (en) 1990-04-25
EP0351784B1 (en) 1993-12-01
DK354589A (da) 1990-01-20
ES2061821T3 (es) 1994-12-16
EP0351784A3 (en) 1990-12-27
DE68911049D1 (de) 1994-01-13
JPH0278622A (ja) 1990-03-19
AU3819089A (en) 1990-01-25
ATE97812T1 (de) 1993-12-15
IT8848208A0 (it) 1988-07-19
DK354589D0 (da) 1989-07-18
PH26117A (en) 1992-02-24
EP0351784A2 (en) 1990-01-24

Similar Documents

Publication Publication Date Title
ITMI911299A1 (it) Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
PT716600E (pt) Composicoes para administracao topica contendo derivados do acido 3-benzoilfenilacetico para o tratamento de doencas inflamatorias oftalmicas
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
DE3779500D1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
AU618443B2 (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
SE7502341L (sv) N-1(1-bensylpyrollidinyl-2-alkyl)-substituerade bensylamider samt förfarande för framställning därav
EP0315113A3 (en) Inner esters of gangliosides with analgesic-antiinflammatory activity
EP0235589A3 (en) Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments
FI896321A7 (fi) Aktiiviainetta sisältävät mikrorakeet, jotka koostuvat pääasiassa kyllästettyjen rasvahappojen triglyseridistä, ja niiden käyttö paikallisesti sairaanhoitoalalla
AU2001261986A1 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
DK1621207T3 (da) Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors
ZA895367B (en) Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component
IT9021768A0 (it) Derivato della melatonina ad attivita' terapeutica in dermatologia
ATE124627T1 (de) Diclofenac-natrium enthaltende pharmazeutische zusammensetzung zur topischen anwendung.
IT1098997B (it) Procedimento per l'applicazione di occhi di supporto su parti di costruzione da supportare in modo oscillabile
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
KR930702015A (ko) 각막 장해 치료제
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale
FI915572A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten ja optisesti aktiivisten 10-(3-amino-4,4-dialkyyli-1-pyrrolidinyyli)-9-fluori-2,3-dihydro-3(S)-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojen valmistamiseksi
IT1232963B (it) Composizioni farmaceutiche topiche contenenti antiistaminici h2
IT7829846A0 (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare.
IT8548976A0 (it) Composizione di un principio farmaceuticamente attivo e fruttosio per alleviare i sintomi di affezioni da raffreddamento in pazienti diabetici

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960701